Northern Biologics - Ownership and Business Overview

Life ScienceCompany

Northern Biologics Ownership

Who owns Northern Biologics?

Northern Biologics is owned by Boehringer Ingelheim. It was acquired on May 14, 2020.

Northern Biologics Business Overview

Where is Northern Biologics headquartered?

Northern Biologics is headquartered in Toronto, Ontario.

What sector is Northern Biologics in?

Northern Biologics is a life science company.

When was Northern Biologics founded?

Northern Biologics was founded in 2014.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 282 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 259 by strategics.

Northern Biologics, Inc.

101 College Street PMCRT 15-701,
Toronto, Ontario M5G 1L7
Canada,
(416) 634-7132
www.northernbiologics.com

Northern Biologics, Inc. is a clinical-stage company with a vision to discover, develop, and advance first-in-class antibody therapeutics to improve patient outcomes in cancer. Northern has developed several highly innovative therapeutic antibodies targeting unique aspects of the tumor microenvironment, including MSC-1, a first-in-class antibody targeting leukemia inhibitory factor (LIF), a key suppressive cytokine in the tumor microenvironment. Northern Biologics was established in 2014 and is based in Toronto, Ontario.


 Subscribe to unlock this and 201,688
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.